Publications by authors named "Barbara Dion"
Article Synopsis
- - Patients with metastatic pancreatic ductal adenocarcinoma (PDAC) were studied to see if high-dose intravenous vitamin C (P-AscH) could improve survival when added to standard chemotherapy (gemcitabine and nab-paclitaxel).
- - The study involved 36 participants, with 34 receiving their assigned treatment, and found that adding P-AscH significantly increased overall survival to 16 months compared to 8.3 months for chemotherapy alone, as well as improved progression-free survival.
- - Importantly, the addition of P-AscH did not harm patients' quality of life or increase side effects, suggesting it is a safe and beneficial adjunct treatment.
